ART4 and Sepsis: In the current study, we report that circulating levels of the immune-derived glycoprotein suPAR can discriminate between clinically relevant subsets of SI-AKI severity (highest AKI stage) and patients that died or required RRT at any time point within 7 days of sepsis diagnosis.